AIM ImmunoTech (AIM) Receivables - Other (2018 - 2026)
AIM ImmunoTech's (AIM) quarterly Receivables - Other came in at -$7000.0 in Q1 2026, down 136.84% YoY from $19000.0 in Q1 2025, and down 136.84% on a QoQ basis from $19000.0 in Q1 2025.
AIM ImmunoTech (AIM) Receivables - Other (2018 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 8 years of Receivables - Other data on file, last reported at -$7000.0 in Q1 2026.
- Quarterly Receivables - Other fell 136.84% year-over-year to -$7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 17552.63% YoY) and the FY2025 annual result came in at $7000.0, changed N/A from the prior year.
- Receivables - Other eased to -$7000.0 in Q1 2026, from $19000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.7 million in Q3 2023 to a low of -$7000.0 in Q1 2026.
- A 4-year average of $1.0 million and a median of $1.6 million in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other soared 50.55% — and 2026, when it sank 136.84%.
- Tracing AIM's Receivables - Other over 4 years: stood at $1.7 million in 2022, then rose by 0.54% to $1.7 million in 2023, then sank by 98.87% to $19000.0 in 2025, then plunged by 136.84% to -$7000.0 in 2026.
- The last three Receivables - Other figures came in at -$7000.0 (Q1 2026), $19000.0 (Q1 2025), and $1.7 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | AIM ImmunoTech | 4.34 Mn | -5.62 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Sep 30, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Mar 31, 2021 | 1.09 Mn |
| Mar 31, 2021 | 1.09 Mn |
| Dec 31, 2020 | 1.09 Mn |
| Dec 31, 2020 | 1.09 Mn |
| Sep 30, 2020 | -6,000.00 |
| Sep 30, 2020 | -6,000.00 |
| Mar 31, 2020 | 776,000.00 |
| Mar 31, 2020 | 776,000.00 |